论文部分内容阅读
目的观察醒脑静注射液治疗重度颅脑损伤的催醒疗效。方法将160例因颅脑损伤所致昏迷的患者(Glasgow评分3～8分)随机分为两组,均予常规治疗,包括依手术指征清除颅内血肿、去骨瓣减压术、脱水降颅内压治疗、抗感染及营养支持治疗等。治疗组(醒脑静注射液治疗组)80例患者在对照组(常规治疗组)基础上加用醒脑静注射液。根据Glasgow评分进行评价。结果治疗组Glasgow昏迷评分(GCS)升高较对照组有显著性差异(p<0.05)。结论醒脑静注射液对治疗重型颅脑损伤后昏迷的催醒治疗疗效确切,是可靠的一种药物。
Objective To observe the effect of Xingnaojing injection in arousal of severe craniocerebral injury. Methods 160 patients with unconsciousness due to craniocervical injury (Glasgow score 3 to 8) were randomly divided into two groups, and were given routine treatment, including intracranial hematoma removal according to the operation indications, decompressive craniectomy, dehydration Reduce intracranial pressure treatment, anti-infective and nutritional support and treatment. Treatment group (Xingnaojing injection treatment group) 80 patients in the control group (conventional treatment group) plus Xingnaojing injection. Evaluate based on Glasgow score. Results The Glasgow coma score (GCS) in the treatment group was significantly higher than that in the control group (p <0.05). Conclusion Xingnaojing Injection is a reliable drug for the treatment of coma after wakefulness treatment of severe traumatic brain injury.